Author:
Veal G J, ,Errington J,Tilby M J,Pearson A D J,Foot A B M,McDowell H,Ellershaw C,Pizer B,Nowell G M,Pearson D G,Boddy A V
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Ando M, Minami H, Ando Y, Saka H, Sakai S, Yamamoto M, Sasaki Y, Shimokata K, Hasegawa Y (2000) Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level. Clin Cancer Res 6: 4733–4738
2. Calvert AH, Newell DR, Gumbrell LA, O’Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748–1756
3. Chatelut E, Pivot X, Otto J, Chevreau C, Thyss A, Renee N, Milano G, Canal P (2000) A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage. Eur J Cancer 36: 264–269
4. Cooper B, Veal GJ, Radivoyevitch T, Tilby MJ, Meyerson HJ, Lazarus HM, Koc ON, Creger RJ, Pearson G, Nowell G, Gosky D, Ingalls ST, Hoppel CL, Gerson SL (2004) A Phase I and pharmacodynamic study of fludarabine, carboplatin and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. Clin Cancer Res 10: 6830–6839
5. Dunkel IJ, Boyett JM, Yates A, Rosenblum M, Garvin Jr JH, Bostron BC, Goldman S, Sender LS, Gardner SL, Li H, Allen JC, Finlay JL (1998) High-dose carboplatin, thiotepa and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 16: 222–228
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献